Gollob Jared — SEC Form 4 filings
SEC reporting owner CIK 1821198. 9 Form 4 filings on record with FilingPulse; latest filed 2026-03-04.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-09 to 2026-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 9 filings — 217,726 shares, $12,908,563 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 29,264 shares @ $60.37 ($1,766,668) in Kymera Therapeutics, Inc., filed 2025-10-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Medical Officer | 9 | — | 29 legs · 217,726 sh · $12,908,563 | 24 |
Form 4 filings — Gollob Jared
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 17,650 @ $0 · Sale (S): 1,510 @ $87.75 · Sale (S): 1,055 @ $88.50 · Sale (S): 3,048 @ $89.66 · Sale (S): 492 @ $84.00 · Sale (S): 2,519 @ $85.04 · +3 more | EDGAR |
| 2025-12-08 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 49,307 @ $5.33 · Sale (S): 13,759 @ $87.37 · Sale (S): 18,357 @ $88.02 · Sale (S): 3,929 @ $89.43 · Sale (S): 8,562 @ $90.12 · Sale (S): 3,300 @ $91.46 · +2 more | EDGAR |
| 2025-10-15 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 28,999 @ $1.31 · Option exercise (M): 22,210 @ $2.08 · Sale (S): 29,264 @ $60.37 · Sale (S): 8,963 @ $61.49 · Sale (S): 14,896 @ $62.72 · Sale (S): 6,453 @ $63.09 · +2 more | EDGAR |
| 2025-10-14 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 800 @ $1.31 · Option exercise (M): 673 @ $2.08 · Sale (S): 3,114 @ $60 · Option exercise (M): 800 (derivative) @ $0 · Option exercise (M): 673 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 30,000 @ $0 · Sale (S): 4,695 @ $30.33 · Sale (S): 1,045 @ $31.00 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-07-16 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 16,455 @ $2.08 · Sale (S): 16,455 @ $45.15 · Option exercise (M): 23,145 @ $2.08 · Sale (S): 13,281 @ $45.59 · Sale (S): 9,864 @ $46.10 · Option exercise (M): 16,455 (derivative) @ $0 · +1 more | EDGAR |
| 2024-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 24,375 @ $0 · Sale (S): 2,022 @ $41.41 · Sale (S): 1,106 @ $42.39 · Sale (S): 216 @ $43.26 · Grant/award (A): 146,250 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 400 @ $2.08 · Sale (S): 400 @ $45 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 46,137 @ $2.08 · Sale (S): 38,739 @ $35.39 · Sale (S): 7,398 @ $36.09 · Option exercise (M): 46,137 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1821198 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →